Rua launches NZ$2m capital raise in bid to reach ‘self-sustaining position’ by Adam Sheldon November 4, 2025February 21, 2026 Rua Bioscience is aiming to raise up to NZ$2 million (A$1.7m) as it looks to expand […]
Financial news in brief: Elixinol addresses funding concerns; Aurora growth helped by Australia; Avecho lifts cash, progresses trial; Cann receives NAB extension to finalise settlement; IRX reports lean quarter by Adam Sheldon November 4, 2025February 21, 2026
Provocatus partners with ANTG, Sativite and Novachem to expand veteran access by Adam Sheldon November 4, 2025November 4, 2025
Breathe Life Sciences launches Curaleaf medical inhalation device by Adam Sheldon November 3, 2025November 3, 2025
Little Green Pharma revenue climbs 10% to $10m in September quarter by Adam Sheldon October 30, 2025November 3, 2025
Record revenue for Bioxyne but cash deficit rises after flower investment by Steve Jones October 30, 2025November 3, 2025
Legalise Cannabis MP says Labor ‘lacks courage’ after rejecting reform by Adam Sheldon October 29, 2025November 3, 2025
Industry vows to keep up the fight as AMA snubs offer of dialogue by Steve Jones October 29, 2025October 29, 2025
News in brief: ASX questions Neurotech over funding; participants sought for endometriosis trial in Sydney by Adam Sheldon October 29, 2025February 21, 2026
NSW holds line on medical cannabis driving defence as Drug Summit response stops short of reform by Adam Sheldon October 28, 2025February 21, 2026
